Diffuse and Focal Corticospinal Tract Disease and Its Impact on Patient Disability in Multiple Sclerosis

Journal of Neuroimaging

Volumn 25, Issue 2, 2015, Pages 200-206

  Tovar Moll, Fernanda ^a,b,c   Evangelou, Iordanis E ^a   Chiu, Annie W ^a   Auh, Sungyoung ^a   Chen, Christina ^a   Ehrmantraut, Mary ^a   Ohayon, Joan M ^a   Richert, Nancy ^a   Bagnato, Francesca ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Black holes; Diffusion tensor imaging; Multiple sclerosis; White matter damage

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSE CORTICOSPINAL TRACT DISEASE; DIFFUSION TENSOR IMAGING; ECHO PLANAR IMAGING; EXPANDED DISABILITY STATUS SCALE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; FOCAL CORTICOSPINAL TRACT DISEASE; FRACTIONAL ANISOTROPY; HUMAN; LEFT HEMISPHERE; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PHYSICAL DISABILITY; PYRAMIDAL TRACT; RIGHT HEMISPHERE; SENSORY DYSFUNCTION; SINGLE DRUG DOSE; TIMED 25 FOOT WALK TEST; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; DISABILITY; GAIT DISORDERS, NEUROLOGIC; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPINAL CORD DISEASE;

ADULT; DIFFUSION TENSOR IMAGING; DISABILITY EVALUATION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PYRAMIDAL TRACTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPINAL CORD DISEASES;

EID: 84924346695     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12171     Document Type: Article

References (44)

1. Tillema JM, Pirko I. Neuroradiological evaluation of demyelinating disease. Ther Adv Neurol Disord 2013;6:249-268.
2. Barkhof F. MRI in multiple sclerosis: correlation with Expanded Disability Status Scale (EDSS). Mult Scler 1999;5:283-286.
3. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209-219.
4. O'Sullivan M, Singhal S, Charlton R, et al. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology 2004;62:702-707.
5. Tovar-Moll F, Moll J, Bramati IE, et al. The human pyramidal syndrome Redux. Neuroreport 2007;18:1417-1421.
6. Tir M, Delmaire C, Besson P, et al. The value of novel MRI techniques in Parkinson-plus syndromes: diffusion tensor imaging and anatomical connectivity studies. Rev Neurol (Paris). 2014 Mar 20. pii: S0035-3787(14)00754-1. doi: 10.1016/j.neurol.2013.10.013. [Epub ahead of print]
7. Bonilha L, Rorden C, Fridriksson J. Assessing the clinical effect of residual cortical disconnection after ischemic strokes. Stroke 2014;45:988-993.
8. Bucci M, Mandelli ML, Berman JI, et al. Quantifying diffusion MRI tractography of the corticospinal tract in brain tumors with deterministic and probabilistic methods. Neuroimage Clin 2013;3:361-368.
9. Rovaris M, Iannucci G, Falautano M, et al. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci 2002;195:103-109.
10. Wilson M, Tench CR, Morgan PS, et al. Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry 2003;74:203-207.
11. Oh J, Henry RG, Genain C, et al. Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry 2004;75:1281-1286.
12. Hickman SJ, Wheeler-Kingshott CAM, Jones SJ, et al. Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis. AJNR Am J Neuroradiol 2005;26:951-956.
13. Trip SA, Wheeler-Kingshott C, Jones SJ, et al. Optic nerve diffusion tensor imaging in optic neuritis. NeuroImage 2006;30:498-505.
14. Lin F, Yu C, Jiang T, et al. Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol 2007;28:278-282.
15. Reich DS, Smith SA, Zackowski KM, et al. Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. NeuroImage 2007;38:271-272.
16. Reich DS, Zackowski KM, Gordon-Lipkin EM, et al. Corticospinal tract abnormalities are associated with weakness in multiple sclerosis. AJNR Am J Neuroradiol 2008;29:333-339.
17. Ceccarelli A, Rocca MA, Valsasina P, et al. Structural and functional magnetic resonance imaging correlates of motor network dysfunction in primary progressive multiple sclerosis. Eur J Neurosci 2010;31:1273-1280.
18. Ozturk A, Smith SA, Gordon-Lipkin EM, et al. MRI of the corpus callosum in multiple sclerosis: association with disability. Mult Scler 2010;16:166-177.
19. Gorgoraptis N, Wheeler-Kingshott CA, Jenkins TM, et al. Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. Mult Scler 2010;16:555-565.
20. Giorgio A, Palace J, Johansen-Berg H, et al. Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis. J Magn Reson Imaging 2010;31:309-316.
21. Hu B, Ye B, Yang Y, et al. Quantitative diffusion tensor deterministic and probabilistic fiber tractography in relapsing-remitting multiple sclerosis. Eur J Radiol 2011;79:101-107.
22. Liu Y, Duan Y, He Y, et al. Whole brain white matter changes revealed by multiple diffusion metrics in multiple sclerosis: a TBSS study. Eur J Radiol 2012;81:2826-2832.
23. Onu M, Roceanu A, Sboto-Frankenstein U, et al. Diffusion abnormality maps in demyelinating disease: correlations with clinical scores. Eur J Radiol 2012;81:e386-e391.
24. van der Walt A, Kolbe SC, Wang YE, et al. Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes. PLoS One 2013;8:e83825. doi: 10.1371/journal.pone.0083825. eCollection 2013.
25. Naismith Xu J, Klawiter EC, Lancia S, et al. Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology 2013;80:2201-2209.
26. Bester M, Lazar M, Petracca M, et al. Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis. J Neurol Sci 2013;330:61-66.
27. Pardini M, Bergamino M, Bommarito G, et al. Structural correlates of subjective and objective memory performance in multiple sclerosis. Hippocampus 2014;24:436-445.
28. Bagnato F, Jeffries N, Richert ND, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 2003;126:1782-1789.
29. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
30. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
31. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
32. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-882.
33. Tovar-Moll F, Evangelou IE, Chiu AW, et al. Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. AJNR Am J Neuroradiol 2009;30:1380-1386.
34. Woods RP, Grafton ST, Holmes CJ, et al. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 1998;22:139-152.
35. Gupta S, Solomon JM, Tasciyan TA, et al. Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis. Mult Scler 2005;11:658-668.
36. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-489.
37. Jezzard P, Balaban RS. Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med 1995;34:65-73.
38. Jiang H, van Zijl PC, Kim J, et al. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006;81:106-116.
39. Mori S, Crain BJ, Chacko VP, et al. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999;45:265-269.
40. Wakana S, Caprihan A, Panzenboeck MM, et al. Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 2007;36:630-644.
41. Fisher E, Chang A, Fox RJ, et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann Neurol 2007;62:219-228.
42. van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754.
43. Truyen L, Van Waesberghe JHTM, Van Walderveen MAA, et al. Accumulation of T1 hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476.
44. Weaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 2002;15:435-455.